Literature DB >> 893676

Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.

L M Buja, A J Tofe, P V Kulkarni, A Mukherjee, R W Parkey, M D Francis, F J Bonte, J T Willerson.   

Abstract

This study was performed to elucidate the localization at the cellular level of technetium-99m phosphorus ((99m)Tc-P) radiopharmaceuticals in acute myocardial infarcts and the mechanisms responsible for (99m)Tc-P uptake in acute myocardial infarcts and other tissues. In 20 dogs with proximal left anterior descending coronary arterial ligation for 1-3 days, elevated calcium levels were measured at all sites of increased (99m)Tc-P uptake (acute myocardial infarcts, necrotic thoracotomy muscle, lactating breast, and normal bone); however, a consistent linear relationship between (99m)Tc-P and calcium levels was not observed. A strong correlation (r = 0.95 and 0.99, n = 2 dogs) was demonstrated between levels of (3)H-diphosphonate and (99m)Tc-P in infarcted myocardium. Autoradiographic studies with (3)H-diphosphonate revealed extensive labeling in the infarct periphery which contained necrotic muscle cells with features of severe calcium overloading, including widespread hypercontraction as well as more selective formation of mitochondrial calcific deposits. Autoradiography also demonstrated labeling of a small population of damaged border zone muscle cells which exhibited prominent accumulation of lipid droplets and focal, early mitochondrial calcification. Cell fractionation studies revealed major localization of both (99m)Tc-P and calcium in the soluble supernate and membrane-debris fractions of infarcted myocardium and less than 2% of total (99m)Tc-P and calcium in the mitochondrial fractions; however, electron microscopic examination showed that mitochondria with calcific deposits were not preserved in the mitochondrial fractions. In vitro studies evaluating the role of serum protein binding on tissue uptake of (99m)Tc-P agents demonstrated that, in spite of significant complexing with serum proteins, serum (99m)Tc-P activity retained the ability to adsorp to calcium hydroxyapatite and amorphous calcium phosphate. In vivo studies showed that concentration of human serum albumin (labeled with iodine-131) in infarcted myocardium reached a maximum of only 3.8 times normal after a circulation time of 96 h, whereas (99m)Tc-P uptake was at least 10 times normal after a circulation time as short as 1 h. It is concluded that: (a) (99m)Tc-P uptake in acutely infarcted myocardium, and possibly other types of soft tissue damage, is limited to necrotic and severely injured cells; (b) concentration of (99m)Tc-P results from selective adsorption of (99m)Tc-P with various forms of tissue calcium stores, including amorphous calcium phosphate, crystalline hydroxyapatite, and calcium complexed with myofibrils and other macromolecules, possibly supplemented by calcium-independent complexing with organic macromolecules; and (c) lack of a linear relationship between (99m)Tc-P and tissue calcium levels mainly results from local differences in composition and physicochemical properties of tissue calcium stores and from local variations in levels of blood flow for delivery of (99m)Tc-P agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893676      PMCID: PMC372418          DOI: 10.1172/JCI108825

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Superiority of alcoholic over aqueous fixation in the histochemical detection of calcium.

Authors:  S RENAUD
Journal:  Stain Technol       Date:  1959-09

2.  Protein chromatography on calcium phosphate columns.

Authors:  S HJERTEN; O LEVIN; A TISELIUS
Journal:  Arch Biochem Biophys       Date:  1956-11       Impact factor: 4.013

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Rationale and radiopharmaceuticals for myocardial imaging.

Authors:  N D Poe
Journal:  Semin Nucl Med       Date:  1977-01       Impact factor: 4.446

5.  Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.

Authors:  K Wrogemann; S D Pena
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Localization of skeletal-imaging 99mTc chelates in dead cells in tissue culture: concise communication.

Authors:  M K Dewanjee
Journal:  J Nucl Med       Date:  1976-11       Impact factor: 10.057

7.  Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion.

Authors:  R E Coleman; M S Klein; S A Ahmed; E S Weiss; W M Buchholz; B E Sobel
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

8.  Relationships between myocardial perfusion, myocardial necrosis, and technetium--99m pyrophosphate uptake in dogs subjected to sudden coronary occlusion.

Authors:  M L Marcus; R J Tomanek; J C Ehrhardt; R E Kerber; D D Brown; F M Abboud
Journal:  Circulation       Date:  1976-10       Impact factor: 29.690

Review 9.  Myocardial infarct imaging with technetium-labeled complexes.

Authors:  B L Holman; M A Davis; R N Hanson
Journal:  Semin Nucl Med       Date:  1977-01       Impact factor: 4.446

10.  Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium.

Authors:  M A Davis; B L Holman; A N Carmel
Journal:  J Nucl Med       Date:  1976-10       Impact factor: 10.057

View more
  33 in total

1.  Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment.

Authors:  B A Khaw; A Nakazawa; S M O'Donnell; K Y Pak; J Narula
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

2.  Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.

Authors:  R S Beanlands; T D Ruddy; L Bielawski; H Johansen
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.

Authors:  Qiaomei Jin; Juanzhi Zhao; Meng Gao; Yuanbo Feng; Wei Liu; Zhiqi Yin; Tiannv Li; Shaoli Song; Yicheng Ni; Jian Zhang; Dejian Huang; Dongjian Zhang
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

Review 4.  Choosing a nuclear medicine study for cardiovascular applications.

Authors:  W H Moore
Journal:  Tex Heart Inst J       Date:  1996

5.  Technetium-99m pyrophosphate myocardial scintigraphy in the diagnosis of acute rheumatic carditis.

Authors:  A Malhotra; S Radhakrishnan; K S Reddy; P G Gopinath; M L Bhatia
Journal:  Indian J Pediatr       Date:  1989 Jul-Aug       Impact factor: 1.967

6.  State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.

Authors:  Vasvi Singh; Rodney Falk; Marcelo F Di Carli; Marie Kijewski; Claudio Rapezzi; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2018-12-19       Impact factor: 5.952

7.  Demonstration of primary tracheobronchial amyloidosis by 99mTc-HMDP bone SPECT.

Authors:  S Yoshida; T Suematsu; T Koizumi; T Motohara; K Oobayashi; Y Takada; H Yamamoto; T Sashikata
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

8.  Myocardial calcifications in infants with congenital heart disease.

Authors:  O Topaz
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

9.  90-minute 99mTc-MDP scintigraphy and 131I-hippuran renography in recently allotransplanted kidneys: evaluation of renal ischemia.

Authors:  H S Thomsen; O Munck; H Løkkegaard
Journal:  Eur J Nucl Med       Date:  1986

10.  18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.

Authors:  Mi-Ae Park; Robert F Padera; Anthony Belanger; Shipra Dubey; David H Hwang; Vikas Veeranna; Rodney H Falk; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.